Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Phibro Animal Health Corporation PAHC
$13.98
-$0.13 (-0.96%)
На 18:00, 12 мая 2023
+33.55%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
562162384.00000000
-
week52high
20.54
-
week52low
11.75
-
Revenue
942300000
-
P/E TTM
21
-
Beta
0.61626200
-
EPS
0.89000000
-
Last Dividend
0.48000000
-
Next Earnings Date
04 мая 2023 г. в 13:00
Описание компании
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy cattle, aquaculture, and dogs. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. The company also offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. In addition, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
Grading company | New grade | Previous grade | Recommendation date |
---|---|---|---|
Barclays | Underweight | Equal-Weight | 25 июл 2022 г. |
Barclays | Equal-Weight | Underweight | 10 янв 2022 г. |
Morgan Stanley | Equal-Weight | 18 ноя 2021 г. | |
Barclays | Underweight | Equal-Weight | 07 июл 2021 г. |
Morgan Stanley | Underweight | Underweight | 13 мая 2021 г. |
Barclays | Underweight | Underweight | 16 сент 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 26 авг 2022 г. |
Morgan Stanley | Equal-Weight | Equal-Weight | 10 ноя 2022 г. |
Roth Capital | Buy | 21 дек 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
---|---|---|---|---|
CORCORAN E THOMAS | A | 20000 | 5000 | 30 авг 2021 г. |
Miller Larry Lee | D | 30000 | 20000 | 09 февр 2021 г. |
Miller Larry Lee | A | 50000 | 50000 | 08 февр 2021 г. |
Miller Larry Lee | D | 0 | 250000 | 08 февр 2021 г. |
CORCORAN E THOMAS | A | 15000 | 5000 | 30 авг 2019 г. |
Bendheim Daniel M | A | 2390 | 2390 | 30 янв 2019 г. |
Bendheim Daniel M | D | 0 | 2390 | 30 янв 2019 г. |
Bendheim Daniel M | D | 0 | 2390 | 30 янв 2019 г. |
Bendheim Daniel M | A | 4890 | 4890 | 29 янв 2019 г. |
Bendheim Daniel M | D | 0 | 4890 | 29 янв 2019 г. |
Новостная лента
Phibro Animal Health Corporation (PAHC) Q3 2023 Earnings Call Transcript
Seeking Alpha
06 мая 2023 г. в 17:28
Phibro Animal Health Corporation (NASDAQ:PAHC ) Q3 2023 Earnings Conference Call May 4, 2023 9:00 AM ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President and CEO Daniel Bendheim - Director and Executive Vice President, Corporate Strategy Conference Call Participants Wolf Chanoff - BofA Securities Brian Wright - ROTH MKM Partners Operator Hello, and thank you for standing by. My name is Regina, and I will be your conference operator today.
Phibro (PAHC) Q3 Earnings Miss Estimates, Gross Margin Up
Zacks Investment Research
04 мая 2023 г. в 13:41
Higher domestic demand and higher average selling prices for dairy products and growth in the companion animal product drive Phibro's (PAHC) Q3 revenues.
Phibro Animal Health (PAHC) Q3 Earnings Lag Estimates
Zacks Investment Research
03 мая 2023 г. в 22:00
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.29 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.33 per share a year ago.
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Zacks Investment Research
14 апр 2023 г. в 11:26
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Financial Results
Business Wire
13 апр 2023 г. в 16:00
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 3, 2023, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 4, 2023, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com.